111 related articles for article (PubMed ID: 12849704)
41. Examination of the sensitivity of T cells to Fas ligation: induction of allospecific apoptosis.
O'Flaherty E; Ali S; Pettit SJ; Kirby JA
Transplantation; 1998 Oct; 66(8):1067-73. PubMed ID: 9808493
[TBL] [Abstract][Full Text] [Related]
42. The Nef-mediated AIDS-like disease of CD4C/human immunodeficiency virus transgenic mice is associated with increased Fas/FasL expression on T cells and T-cell death but is not prevented in Fas-, FasL-, tumor necrosis factor receptor 1-, or interleukin-1beta-converting enzyme-deficient or Bcl2-expressing transgenic mice.
Priceputu E; Rodrigue I; Chrobak P; Poudrier J; Mak TW; Hanna Z; Hu C; Kay DG; Jolicoeur P
J Virol; 2005 May; 79(10):6377-91. PubMed ID: 15858021
[TBL] [Abstract][Full Text] [Related]
43. [Effect of ronggan mixture on cell apoptosis in rats with chronic immune liver injury induced by concanavalin A].
Wang FY; Tang XD; Xu YG
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2008 Sep; 28(9):835-8. PubMed ID: 19065901
[TBL] [Abstract][Full Text] [Related]
44. Susceptibility to apoptosis in insulin-like growth factor-I receptor-deficient brown adipocytes.
Valverde AM; Mur C; Brownlee M; Benito M
Mol Biol Cell; 2004 Nov; 15(11):5101-17. PubMed ID: 15356271
[TBL] [Abstract][Full Text] [Related]
45. Apoptosis pathway of liver cells in chronic hepatitis.
Chen NL; Bai L; Li L; Chen PL; Zhang C; Liu CY; Deng T; Chen H; Jia KM; Zhou ZQ
World J Gastroenterol; 2004 Nov; 10(21):3201-4. PubMed ID: 15457575
[TBL] [Abstract][Full Text] [Related]
46. Role of Fas/Fas ligand-mediated apoptosis in murine contact hypersensitivity.
Xu B; Bulfone-Paus S; Aoyama K; Yu S; Huang P; Morimoto K; Matsushita T; Takeuchi T
Int Immunopharmacol; 2003 Jul; 3(7):927-38. PubMed ID: 12810350
[TBL] [Abstract][Full Text] [Related]
47. Fas/FasL mediates NF-κBp65/PUMA-modulated hepatocytes apoptosis via autophagy to drive liver fibrosis.
Tan S; Liu X; Chen L; Wu X; Tao L; Pan X; Tan S; Liu H; Jiang J; Wu B
Cell Death Dis; 2021 May; 12(5):474. PubMed ID: 33980818
[TBL] [Abstract][Full Text] [Related]
48. [The expression of Fas, FasL and Bcl-2 on RMA cells during the process of apoptosis induced by chemotherapeutic drugs].
Zhu HL; Wang YZ; Yu L; Li B; Yao SQ; Lou FD
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2002 Feb; 10(1):35-9. PubMed ID: 12513834
[TBL] [Abstract][Full Text] [Related]
49. Bcl-2 inhibits calcineurin-mediated Fas ligand expression in antitumor drug-treated baby hamster kidney cells.
Simizu S; Shibasaki F; Osada H
Jpn J Cancer Res; 2000 Jul; 91(7):706-14. PubMed ID: 10920278
[TBL] [Abstract][Full Text] [Related]
50. Inhibition of Fas-induced apoptosis by Bcl-2.
Kawahara A; Kobayashi T; Nagata S
Oncogene; 1998 Nov; 17(20):2549-54. PubMed ID: 9840917
[TBL] [Abstract][Full Text] [Related]
51. Altered apoptotic response and different liver structure during liver regeneration in FGF-2-deficient mice.
Sturm JW; Zhang H; Magdeburg R; Hasenberg T; Bönninghoff R; Oulmi J; Keese M; McCuskey R
Cell Physiol Biochem; 2004; 14(4-6):249-60. PubMed ID: 15319528
[TBL] [Abstract][Full Text] [Related]
52. Role of fas ligand in uveal melanoma-induced liver damage.
Repp AC; Mayhew ES; Howard K; Alizadeh H; Niederkorn JY
Graefes Arch Clin Exp Ophthalmol; 2001 Oct; 239(10):752-8. PubMed ID: 11760036
[TBL] [Abstract][Full Text] [Related]
53. Regulation of T-cell apoptosis: a mixed lymphocyte reaction model.
O'Flaherty E; Wong WK; Pettit SJ; Seymour K; Ali S; Kirby JA
Immunology; 2000 Jul; 100(3):289-99. PubMed ID: 10929050
[TBL] [Abstract][Full Text] [Related]
54. Differential expression of the Fas-Fas ligand system on cytokine-induced apoptotic cell death in mouse osteoblastic cells.
Ozeki N; Mogi M; Nakamura H; Togari A
Arch Oral Biol; 2002 Jul; 47(7):511-7. PubMed ID: 12208075
[TBL] [Abstract][Full Text] [Related]
55. The caspase-8/Bid/cytochrome c axis links signals from death receptors to mitochondrial reactive oxygen species production.
Kim WS; Lee KS; Kim JH; Kim CK; Lee G; Choe J; Won MH; Kim TH; Jeoung D; Lee H; Kim JY; Ae Jeong M; Ha KS; Kwon YG; Kim YM
Free Radic Biol Med; 2017 Nov; 112():567-577. PubMed ID: 28888620
[TBL] [Abstract][Full Text] [Related]
56. Tissue transglutaminase (TG2) acting as G protein protects hepatocytes against Fas-mediated cell death in mice.
Sarang Z; Molnár P; Németh T; Gomba S; Kardon T; Melino G; Cotecchia S; Fésüs L; Szondy Z
Hepatology; 2005 Sep; 42(3):578-87. PubMed ID: 16108039
[TBL] [Abstract][Full Text] [Related]
57. Deletion of Mir155 prevents Fas-induced liver injury through up-regulation of Mcl-1.
Chen W; Han C; Zhang J; Song K; Wang Y; Wu T
Am J Pathol; 2015 Apr; 185(4):1033-44. PubMed ID: 25794705
[TBL] [Abstract][Full Text] [Related]
58. Disparate roles for TNF-alpha and Fas ligand in concanavalin A-induced hepatitis.
Ksontini R; Colagiovanni DB; Josephs MD; Edwards CK; Tannahill CL; Solorzano CC; Norman J; Denham W; Clare-Salzler M; MacKay SL; Moldawer LL
J Immunol; 1998 Apr; 160(8):4082-9. PubMed ID: 9558119
[TBL] [Abstract][Full Text] [Related]
59. A toll-like receptor 9 agonist sensitizes mice to mitochondrial dysfunction-induced hepatic apoptosis via the Fas/FasL pathway.
Song B; Aoki S; Liu C; Ito K
Arch Toxicol; 2019 Jun; 93(6):1573-1584. PubMed ID: 30993380
[TBL] [Abstract][Full Text] [Related]
60. Anti-Fas antibody differentially regulates apoptosis in Fas ligand resistant carcinoma lines via the caspase 3 family of cell death proteases but independently of bcl2 expression.
Crowe DL; Boardman ML; Fong KS
Anticancer Res; 1998; 18(5A):3163-70. PubMed ID: 9858879
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
